All Articles

New antibiotic launched

Pfizer has launched Zavicefta (ceftazidime-avibactam) for adults hospitalised with serious infections

Verapamil for rhinosinusitis?

Verapamil dramatically improves symptom scores in patients with chronic rhinosinusitis and nasal polyps

NSAIDs and paracetamol linked to hearing loss

NSAIDs and paracetamol might increase the risk of hearing loss, according to an analysis of 55,850 women

Rotavirus vaccine is preventing gastroenteritis in infants

Infant rotavirus vaccine reduces the number of episodes of acute gastroenteritis by up to half and saves £12.5m a year

Teva launches reformulated levothyroxine range

Teva has launched a reformulated version of levothyroxine, including two previously unavailable strengths

Xultophy approved for renal impairment

Xultophy has been approved for adults with type 2 diabetes and moderate renal impairment

Update: media scare stories cutting statin use?

Media stories questioning the safety of statins are causing people to stop taking the drugs

Update: Enstilar – new psoriasis drug

Enstilar (calcipotriol and betamethasone dipropionate) is a new topical, alcohol-free, foam spray for plaque psoriasis

Massive increase in ADHD prescribing

Prescriptions for ADHD drugs in the UK increased by almost 800 per cent between 2000 and 2015

Benzodiazepines could significantly increase flu risk

Benzodiazepines may increase mortality more than 20-fold in people with influenza-like illness, new research finds

Actavis adds gliclazide 40mg

Actavis has added gliclazide 40mg tablets alongside the existing 80mg tablet offer

New ticagrelor dose

Marketing authorisation has been granted for a 60mg dose of ticagrelor for patients who have suffered a heart attack  

New lung cancer drug

The European Commission has granted marketing authorisation for necitumumab (Portrazza) for lung cancer

Ezetimibe indication widened

The MHRA recently extended the indication for ezetimibe (Ezetrol)

Dementia script numbers rise but costs fall

The number of prescriptions for drugs for Alzheimer’s disease rose more than six-fold over the past decade

GORD quality standards

NICE has published nine quality standards covering GORD in children and young people

Cyramza’s new cancer indications

The European Commission recently approved two new indications for ramucirumab (Cyramza)

Dispensary: Reltebon price cut

Actavis has reduced the list price of Reltebon (oxycodone hydrochloride) prolonged-release tablets

Entresto: a new heart failure drug

Entresto (sacubitril plus valsartan) is now available for adults with symptomatic chronic heart failure.

Dulaglutide gets green light in Scotland

The Scottish Medicines Consortium has accepted Trulicity (dulaglutide) for use in NHS Scotland.  
Previous 1 2 3 Next

Latest

Public urged to visit a pharmacy this winter

Stay Well This Winter, the annual campaign to ease seasonal pressures on urgent care and emergency services, starts next...

DH wants more information on generics prices

The Government is seeking greater transparency over the pricing of generics. A consultation runs until November

Views

Flu jabs: let’s do a fantastic job

By NPA chief pharmacist Leyla Hannbeck. If Australia’s experience is anything to go by, we all need to be ready to dea...

Popular

Watching Briefs: Baby & child health

We round up all the latest product news in the baby and child health category

Train your team: Muscle & joint pain

This Train Your Team checklist provides support and information to run a team training session on muscle and joint pain

Inspire healthier lifestyles to reduce dementia risk

Three-quarters of adults would consider changes to their lifestyle to reduce their risk of developing dementia